Coherus Biosciences | Capitaux D'Emprunt



Loan Capital Changement Date
AbbVie USD 60.34B 1.83B 2024-12
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amarin USD 0 0 2025-03
Amgen USD 54.01B 2.54B 2025-03
Baxter International USD 10.37B 63M 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
Fujifilm JPY 470.8B 838M 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Merck USD 33.48B 978M 2025-03
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacira USD 381.29M 2.26M 2025-03
Perrigo USD 3.59B 9.6M 2025-03
Pfizer USD 57.64B 234M 2025-03
PTC Therapeutics USD 2.12B 179K 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Teva Pharmaceutical Industries USD 16.23B 228M 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Xencor USD 101.84M 13.32M 2025-03
Zoetis USD 5.23B 7M 2025-03



Coherus Biosciences Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.